Financial Statements · Financial Reporting
PharmaSynth AS
Official identifier 11044101Record date 31 Dec 2024
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2024
- Period start
- 1 Jan 2024
- Submitted date
- 30 Jun 2025
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 1,123,717 |
| Balance sheet | Cash and cash equivalents | 743,028 |
| Balance sheet | Current assets | 968,754 |
| Balance sheet | Current liabilities | 75,325 |
| Balance sheet | Equity | 1,048,392 |
| Balance sheet | Share capital at nominal value | 57,180 |
| Balance sheet | Non-current assets | 154,963 |
| Balance sheet | Retained earnings (loss) from previous periods | 832,973 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -40,275 |
| Income statement scheme 1 | Labour costs | -373,405 |
| Income statement scheme 1 | Revenue | 586,714 |
| Income statement scheme 1 | Annual period profit / loss | 152,148 |
| Income statement scheme 1 | Operating profit (loss) | 128,395 |
| Income statement scheme 1 | Profit (loss) before income tax | 152,148 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 832,973 |
| Kasumi jaotamise otsus | Retained earnings (loss) from previous periods | 832,973 |
| Note: Labour costs | Employees | 8 |
| Note: Labour costs | Labour costs | 373,405 |
Linked company
Company: PharmaSynth AS